One of the most common stories I hear from new clients goes something like this.
They were finally diagnosed with small intestinal bacterial overgrowth (SIBO) after months — sometimes years — of digestive symptoms. During that time, many people are told they have irritable bowel syndrome or are advised to try restrictive approaches like the FODMAP diet to manage symptoms. Eventually, their doctor prescribes antibiotics such as rifaximin, and for the first time in a long time, they start to feel better. The bloating eased. Their digestion felt calmer. They could eat a little more normally again.
But then, a few weeks after finishing the medication, the symptoms slowly crept back.
I remember one client — I’ll call her Sarah — who told me she felt almost 90% better while she was taking rifaximin. She was hopeful that she had finally found the answer. But within about two weeks of finishing the course, the bloating, gas, abdominal pain, and food sensitivity she had been dealing with for years began returning almost exactly the way they had before.
If you’ve had a similar experience, you’re not alone.
Many people notice significant improvement during treatment, only to see their symptoms return not long after the antibiotics are finished. Others go through multiple rounds of treatment and feel like they’re stuck in a cycle where the symptoms improve temporarily but never fully resolve; a frustrating cycle of SIBO relapse.
This experience can be incredibly discouraging, especially after finally feeling hopeful that something was working.
The important thing to understand is that antibiotics like rifaximin can absolutely play a helpful role in addressing SIBO. But in many situations, they are only one piece of a larger puzzle.
When symptoms return quickly after treatment, it’s often because one of three important factors hasn’t been addressed.
In this article, we’ll walk through the three most common reasons people experience SIBO recurrence after antibiotics and what needs to happen differently for the results to last.
1. The Wrong Overgrowth Pattern May Be Treated
One of the biggest reasons antibiotics sometimes don’t seem to work for SIBO is that not all SIBO is the same.
While SIBO generally refers to bacterial overgrowth in the small intestine, different gas patterns identified on breath testing reflect different microbial activity and can be associated with different symptoms and treatment approaches.
These subtypes are usually categorized based on the gases produced by the microbes, which are identified through breath tests that measure gas production after a lactulose or glucose challenge:
- Hydrogen
- Methane
- Hydrogen sulfide
Each of these patterns behaves differently in the body, which is why the treatment approach can vary significantly between them.
Rifaximin is one of the most commonly prescribed antibiotics for SIBO, and it can be very effective in the right situation because it works locally in the gut to reduce bacterial overgrowth in the small intestine, particularly hydrogen-producing bacteria.
However, the other patterns involve different types of microbes that don’t respond the same way.
For example, methane overgrowth is associated with organisms called methanogens. In the medical literature, this pattern is now often referred to as intestinal methanogen overgrowth (IMO) rather than traditional SIBO. These organisms respond to different antimicrobial strategies than hydrogen-producing bacteria, which is why rifaximin alone is often not sufficient. In clinical practice, methane overgrowth is typically addressed with combination therapy rather than rifaximin by itself. I explain this in much more detail in my article on methane SIBO treatment.
Hydrogen sulfide patterns are another situation where rifaximin alone often doesn’t fully address what’s going on. Hydrogen sulfide is produced by sulfur-reducing bacteria that rifaximin does not directly target.
In some cases, rifaximin may still lead to partial improvement because it can reduce hydrogen-producing bacteria that hydrogen sulfide producers rely on as a fuel source. But when the sulfur-reducing organisms themselves aren’t addressed, symptoms often return once treatment ends.
Addressing hydrogen sulfide patterns often involves a broader approach that may include supporting sulfur metabolism, using binders to help manage excess hydrogen sulfide, and sometimes incorporating specific herbal antimicrobials that are used to target sulfur-reducing bacteria. I go into much more detail about this in my article on hydrogen sulfide SIBO treatment.
Because rifaximin is frequently prescribed as a blanket treatment for SIBO, some patients are unknowingly addressing only part of the overgrowth. This is one reason people sometimes describe two very common experiences: either the antibiotics didn’t seem to help at all, or symptoms improved during treatment but returned shortly after the medication was stopped, which helps explain why stories about rifaximin SIBO success can vary so widely from person to person.
But even when the correct microbial pattern is targeted, another common issue still remains.
2. The Bacterial Load Often Hasn’t Been Reduced Enough Yet
Another very common reason symptoms return after treatment is simply that the bacterial overgrowth hasn’t been reduced enough yet.
When bacteria accumulate in the small intestine, the population can become quite large. And in many cases, it takes more than a single round of treatment to meaningfully bring those levels down.
In clinical practice, it’s very common for people to need more than one round of therapy to meaningfully reduce the overgrowth. In general, when breath test gas levels start very high, it often takes multiple rounds of treatment to bring those levels down into the normal range.
SIBO specialist Dr. Allison Siebecker has noted that a single round of antimicrobial treatment — typically about two weeks of a prescription antibiotic or four to six weeks of herbal antimicrobials — tends to lower gas levels by roughly 20–30 parts per million on average. In our practice, one helpful way we often estimate how many rounds of treatment may be needed is by looking at the peak gas levels on the breath test and using that typical reduction as a rough rule of thumb.
For example, if someone’s hydrogen level peaks around 100 parts per million, it’s very unlikely that a single round of treatment will bring those levels all the way down into the normal range. Using that rough reduction of about 20–30 parts per million per round, someone starting around 100 parts per million would typically need at least three rounds of treatment — and sometimes more — to bring those levels down into the normal range. That doesn’t mean the first round didn’t work; it simply means the bacterial population hasn’t been reduced far enough yet.
This concept is actually similar to something many people already understand about antibiotics for infections.
If someone is prescribed a 10-day course of antibiotics for a sinus infection, most people know that stopping after three or four days — even if symptoms start improving — usually isn’t enough to fully clear the infection. The remaining bacteria can simply begin multiplying again.
Something similar can happen with SIBO. If treatment reduces part of the bacterial population but doesn’t bring it down far enough, the remaining microbes can begin rebuilding once treatment stops.
Unfortunately, many people with SIBO are only prescribed a single round of antibiotics. The pattern we often see looks something like this:
- One round of antibiotics
- Symptoms improve during treatment
- The medication stops
- Symptoms gradually return
When treatment stops too early, the bacterial population often hasn’t been reduced enough yet.
Another important factor is timing. Very often when new clients come to us, they tell us they were prescribed a single round of antibiotics and then told to wait and see how things go. If symptoms return, another round may be considered several months later.
The challenge with that approach is that bacteria in the small intestine can begin rebuilding fairly quickly once treatment stops. So by the time another round is prescribed months later, the overgrowth has often already re-established itself.
It’s a bit like trying to drive to a destination that’s three hours away. Let’s say you drive the first leg of the trip for one hour. But instead of continuing from there for the second leg, you drive all the way back home first.
That’s essentially what can happen when months pass between treatment rounds. The overgrowth can rebuild during that time, so you end up right back where you started. When you begin treatment again, you’re only getting back to the same point you reached before rather than actually progressing further toward clearing the overgrowth.
This is why in our practice, when we’re working to fully reduce the overgrowth, we typically keep treatment rounds closer together rather than leaving long gaps in between.
Because repeated rounds of prescription antibiotics aren’t always ideal, we often use herbal antimicrobial protocols as part of the process. That allows us to keep reducing the bacterial population while also supporting the overall gut environment.
After a couple rounds of treatment, we typically retest so we can see how much progress has been made and determine whether additional treatment is still needed. That way we’re not continuing treatment blindly, but we’re also maintaining enough momentum to meaningfully bring the overgrowth down.
A client I worked with — I’ll call him Daniel — had been told he had SIBO about a year before we started working together.
When I asked what treatment he had done, he told me his doctor had prescribed a round of rifaximin. He said it had helped a little at the time. His bloating eased up somewhat, and meals felt slightly easier to tolerate, but the improvement wasn’t dramatic, and he never felt like things had fully resolved. Within a few weeks, his symptoms gradually drifted back to where they had been before.
When I asked what his breath test numbers were, he had no idea.
His doctor’s office had simply called him and said he tested positive for SIBO and that they had sent an antibiotic prescription to the pharmacy.
So I asked him to request a copy of the test report and send it over.
When I reviewed the results, his hydrogen levels had peaked at 108 parts per million.
When I told him that number, he was surprised.
I explained, “Daniel, no wonder you’re still struggling. That level of overgrowth would almost never be expected to clear with just one round of treatment.”
In situations like that, the first round of therapy often reduces the bacterial population somewhat — which is why people may notice some improvement — but it hasn’t actually brought the levels down far enough yet. With a starting level over 100 parts per million, Daniel would almost certainly have needed multiple rounds of treatment to meaningfully bring those levels down.
This type of story is incredibly common. We see versions of it every week in our practice at Nutrition Resolution, and many people reading this will likely recognize their own experience in it.
Even when the bacterial overgrowth itself is addressed successfully, there’s still one more critical factor that determines whether SIBO returns.
3. The Underlying Drivers That Caused SIBO Haven’t Been Addressed
The third major reason SIBO symptoms often return after treatment is that the underlying root causes that allowed the overgrowth to develop in the first place haven’t been addressed.
In a healthy digestive system, several mechanisms are constantly working together to prevent bacteria from accumulating in the small intestine.
For example, the small intestine has a natural cleaning wave called the migrating motor complex, which helps sweep bacteria and leftover food particles down into the large intestine between meals. Adequate stomach acid helps limit how many microbes survive the stomach and enter the small intestine. Bile and digestive enzymes also play an important role in controlling microbial growth and supporting proper digestion.
When these systems are working well, bacteria generally don’t accumulate in the small intestine in large numbers.
But when one or more of these protective mechanisms becomes impaired, the environment in the small intestine can start to shift in a way that allows bacteria to build up.
SIBO specialist Dr. Allison Siebecker often teaches that there are around 40 different conditions and factors that can contribute to the development of SIBO. In practice, though, it’s very common for more than one factor to be involved. That’s why I tend to think of them as root contributors rather than assuming there is always a single root cause.
Some of the most common contributors we see include:
- Slowed motility of the small intestine, caused by factors such as food poisoning that leads to anti-vinculin antibodies, thyroid dysfunction, certain medications, or other conditions that impair the migrating motor complex
- Low stomach acid or reduced digestive enzyme production
- Impaired bile flow
- Structural issues such as adhesions, scar tissue, or surgical changes to the digestive tract
- Disruption of the gut microbiome and its beneficial bacteria after repeated courses of antibiotics
- Certain conditions that can slow intestinal motility, such as thyroid dysfunction
Interestingly, many of the different contributors described in the SIBO literature ultimately affect the same underlying mechanism: the normal movement of the small intestine.
The migrating motor complex acts as a kind of cleaning wave that sweeps bacteria and debris out of the small intestine between meals. When that system slows down, bacteria can linger in the small intestine longer than they should and begin multiplying.
One of the most well-known ways this can happen is after certain types of food poisoning. In some people, foodborne infections can trigger antibodies such as anti-CdtB and anti-vinculin that interfere with the nerve signaling involved in the migrating motor complex. When that signaling is disrupted, the small intestine’s natural cleaning waves can become less effective, creating an environment where bacterial overgrowth can develop.
When these underlying drivers remain in place, the environment that allowed the overgrowth to develop hasn’t really changed.
So even if antibiotics or antimicrobials temporarily reduce the bacterial population, the small intestine is still vulnerable to the same problem. Over time, bacteria can begin accumulating again and symptoms gradually return.
This is why addressing SIBO usually involves more than simply reducing the bacterial overgrowth itself. It also involves identifying and supporting the underlying digestive processes that help keep the small intestine balanced in the first place, which is ultimately one of the most important steps in how to prevent sibo from coming back.
A cornerstone of our work with clients at Nutrition Resolution is doing a thorough root cause assessment to identify the specific contributors involved in each person’s case. By the time someone finishes working with us, our goal isn’t just that the SIBO has been cleared, but that they also have a clear relapse-prevention plan to support the areas that allowed the overgrowth to develop in the first place.
A client I worked with — I’ll call her Melissa — had already been through several rounds of antibiotic treatment for SIBO before we started working together. Each time she took the antibiotics, her symptoms improved for a while, but the relief never lasted. By the time she came to us, she was starting to feel concerned about the pattern she was stuck in. She wondered how many more times she would need antibiotics and what that might mean long-term if the cycle kept repeating.
As we reviewed her history more closely, it became clear that the entire focus of her previous care had been on reducing the overgrowth itself. No one had ever talked with her about the underlying factors that may have allowed the SIBO to develop in the first place. When I brought that up, she honestly had no idea where to even begin thinking about it. Like many clients, she assumed the only issue was the bacteria themselves.
But when we started digging through her history, we discovered she had a bit of a perfect storm of contributors.
For one, she had been taking a proton pump inhibitor for years for acid reflux. Long-term suppression of stomach acid can reduce one of the body’s natural defenses against bacterial overgrowth in the small intestine. She had also undergone a hysterectomy years earlier, which meant there was a possibility of small adhesions or scar tissue in the abdominal cavity — something that can sometimes alter the movement of the intestines and create pockets where bacteria can accumulate more easily.
On top of that, she had experienced multiple episodes of food poisoning over the years, and she was living with hypothyroidism — both of which can affect the normal movement of the small intestine. When you look at those factors together, it becomes easier to see how the environment for SIBO to develop may have been created in the first place.
Once we identified those contributors, our plan focused not only on addressing the overgrowth itself, but also on supporting the systems that help keep the small intestine balanced long term. We worked with her physician to ensure her thyroid function was well managed, incorporated the right type of abdominal manual therapy to help address potential adhesions, and supported her small intestinal motility as part of her longer-term plan.
Interestingly, Melissa’s acid reflux also improved significantly once her methane overgrowth was addressed. Methane SIBO can slow digestive movement and increase pressure in the digestive tract, which can contribute to reflux symptoms. As her digestion stabilized, she was able to gradually taper off her PPI with the guidance and approval of her physician.
Stories like Melissa’s are incredibly common. When the bacterial overgrowth is addressed but the underlying contributors are never identified, people often find themselves stuck in the same cycle of temporary improvement followed by relapse. But when those underlying drivers are understood and supported, the results tend to be much more stable over time.
Still stuck in the cycle of SIBO coming back?
If you’ve taken antibiotics like rifaximin, felt better for a while, and then watched your symptoms slowly return, you’re not alone. This is one of the most common patterns we see, and it usually means an important piece of the puzzle hasn’t been addressed yet.
If you’d like help thinking through your situation, you’re welcome to schedule a 15-minute strategy call with me. We’ll talk through what you’ve tried so far, what may have been missed, and whether working together would make sense for you.
Schedule your strategy call here.
Why a More Comprehensive Approach Matters
When you look at the patterns behind why SIBO comes back, it becomes clear that lasting improvement usually requires addressing several layers of the problem at the same time. Unfortunately, this isn’t always how SIBO is typically approached in standard care, where the focus is often placed primarily on reducing the bacterial overgrowth itself.
First, it’s important to correctly identify the overgrowth pattern. As we discussed earlier, not all SIBO behaves the same way. Hydrogen, methane, and hydrogen sulfide patterns involve different organisms and require different treatment strategies, so understanding which pattern is present helps guide the most appropriate approach.
Second, the bacterial population in the small intestine needs to be reduced far enough that the gut environment can stabilize. That means continuing treatment long enough to meaningfully bring gas levels down rather than stopping after a single round before the overgrowth has been fully reduced.
And third, it’s important to identify and support the underlying digestive processes that help prevent bacteria from accumulating in the small intestine in the first place. This is one reason SIBO recurrence rates are often reported to be high — the overgrowth may be reduced, but the underlying conditions that allowed it to develop are never addressed.
That often means taking a closer look at things like small intestinal motility, digestive function, stomach acid levels, bile flow, and the overall gut environment. When those factors are evaluated together, treatment plans can be tailored much more specifically to the individual rather than relying on a one-size-fits-all approach.
In practice, this kind of more comprehensive approach is what tends to produce more stable and lasting improvements. Instead of simply reducing the overgrowth temporarily, the goal becomes restoring the conditions that help keep the small intestine balanced over time.
Want to see how we approach complex gut issues like SIBO?
At Nutrition Resolution, our work focuses on identifying the overgrowth pattern, reducing the bacterial burden adequately, and supporting the underlying digestive processes that help prevent relapse.
You can learn more about our step-by-step approach here.
If Your Symptoms Came Back After Antibiotics
If you took antibiotics like rifaximin and your symptoms returned shortly afterward, it usually doesn’t mean the treatment failed or that nothing will work.
More often, it means the overgrowth wasn’t fully addressed yet — either because the specific overgrowth pattern wasn’t targeted appropriately, the bacterial population wasn’t reduced far enough, and/or the underlying conditions that allowed it to develop were never identified and supported. When those deeper drivers remain in place, the small intestine can gradually drift back into the same pattern again.
The encouraging news is that when those factors are properly identified and addressed, many people are able to break out of that cycle and finally see lasting resolution in their symptoms.
When It’s Time to Get Personalized Help
If you’ve been dealing with SIBO that keeps coming back, you’re likely exhausted from the cycle.
Many of the people who eventually work with us arrive at the same point: they’ve tried rounds of antibiotics, experimented with different diets, and followed the recommendations they were given — yet the symptoms keep resurfacing, and they’re left wondering what they’re missing and continuing the search for answers about why their SIBO keeps coming back.
In our experience, that turning point often comes when someone finally steps back and evaluates the full picture of what’s happening in their digestive system instead of continuing to chase the symptoms alone.
If you’d like help thinking through your situation and what your next step might look like, you’re welcome to schedule a 15-minute strategy call with me. We’ll talk through what you’ve already tried, what may have been overlooked, and whether working together would make sense for you.
Frequently Asked Questions (FAQ)
Can SIBO come back years later?
Yes, SIBO can return even years after successful treatment if the underlying factors that allowed the overgrowth to develop were never addressed. For example, issues such as slowed intestinal motility, low stomach acid, structural changes in the digestive tract, or disruptions in the gut microbiome can continue creating an environment where bacteria accumulate in the small intestine. If those contributors remain in place, the conditions that allowed the overgrowth to develop can eventually lead to recurrence again.
Why does SIBO come back?
There are several reasons why SIBO comes back after treatment. In many cases, the bacterial overgrowth was not fully reduced, the specific gas pattern was not targeted appropriately, or the underlying digestive processes that normally prevent bacterial buildup were never addressed. When those deeper drivers remain in place, the small intestine can gradually drift back into the same pattern over time.
Does SIBO come back after antibiotics?
Yes, SIBO does come back for some people after antibiotic treatment. Antibiotics like rifaximin can be very effective at reducing bacterial overgrowth, but if treatment stops before the bacterial population has been reduced far enough or if underlying contributors are still present, symptoms may gradually return once the medication is finished.
Can Xifaxan make SIBO worse?
In most cases, Xifaxan (rifaximin) does not make SIBO worse. However, people sometimes feel worse temporarily during treatment due to bacterial die-off or shifts in the gut environment. In other cases, symptoms may seem unchanged if the antibiotic was targeting hydrogen-producing bacteria, but the overgrowth pattern involved methane or hydrogen sulfide, which respond differently to treatment.
How long does it usually take to fully clear SIBO?
In many cases, clearing SIBO requires more than one round of treatment. In clinical practice, most people need two to three rounds of antimicrobial therapy to meaningfully reduce the overgrowth. A typical round is about two weeks with prescription antibiotics like rifaximin or four to six weeks with herbal antimicrobials, depending on the approach used. For many people, that means the process of fully reducing the overgrowth often takes several weeks to a few months.
How can you prevent SIBO from coming back?
Preventing SIBO relapse usually requires addressing more than just the bacterial overgrowth itself. First, it’s important to correctly identify the type of overgrowth present so the treatment targets the right microbes. Second, the bacterial population needs to be reduced far enough that gas levels return to the normal range, which often requires more than one round of treatment. And third, the underlying digestive factors that allowed the overgrowth to develop — such as intestinal motility, stomach acid levels, bile flow, and the overall gut environment — need to be supported so the small intestine is less likely to accumulate bacteria again.
